drugset / Trial / NCT05521672
Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease
Phase 1/2
Terminated
2 enrolled
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Effice Servicios Para la Investigacion S.L. · collab
NaSingle-groupOpen-labelTreatment
Summary
A phase II, national, multicenter, uncontrolled and open trial to evaluate the feasibility and safety of laparoscopic administration of adipose derived allogenic mesenchymals stem cells (adMSC), for the treatment of patients with a single inflammatory stenosis in the context of Crohn's disease.
Timeline
- Start
- 2022-10-24
- Primary completion
- 2024-12-13
- Completion
- 2024-12-13
Outcome
Outcome not reported
Stopped (Enrollment): “low recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose derived allogenic mesenchymal stem cells | Cell therapy | 120 cells | Other |